Partnering with The University of South Australia developers of the technology in collaboration with the Australian Department of Defence – Defence Science and Technology Group
Vancouver, British Columbia, March 26, 2020 (GLOBE NEWSWIRE) -- Draganfly Inc. (CSE: DFLY) (OTCQB: DFLYF) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely Piloted Aircraft Systems (“RPAS”), and unmanned vehicle sector, today announced that it has been selected as the exclusive global systems integrator for a project (the “Vital Intelligence Project”) with Vital Intelligence Inc., a healthcare data services & deep learning company in conjunction with the University of South Australia, using technology developed with help from the Australian Department of Defence Science and Technology Group (the “DST”).
The Vital Intelligence Project is a health and respiratory monitoring platform involving utilizing new and existing camera networks as well as UAVs and RPAS being immediately commercialized for health monitoring and detection of infectious and respiratory conditions including monitoring temperatures, heart and respiratory rates, amongst crowds, workforces, airlines, cruise ships, potential at-risk groups, i.e., seniors in care facilities, convention centers, border crossings or critical infrastructure facilities. The breakthrough technology was developed in a collaboration between the University of South Australia and the DST.
Draganfly, in being selected as the exclusive integration partner on March 25, 2020, executed a binding agreement which has an initial budget of up to $1.5M to utilize its engineering, integration and distribution expertise as well as its secure supply chain for immediate commercialization and deployment of the technology.
Dr. Javaan Chahl, Defence Science and Technology Chair at the University of South Australia said, “The University and Defence supported my team’s efforts to develop automation for use in epidemics and disasters. We had imagined the technology being used in a future relief expedition to some far-away place. Now, shockingly, we see a need for its use in our everyday lives immediately. Draganfly’s industrial know-how is quickly helping us ensure our research can save lives.”
“Draganfly has been selected because of its proven leadership in an industry so important to public safety at such a critical time. We look forward to working with global agencies and industry to rapidly deploy this important technology,” said Cameron Chell, CEO of Draganfly.
“Draganfly is honored to work on such an important project given the current pandemic facing the world with COVID-19. Health and respiratory monitoring will be vital for not only detection, but also utilizing the data to understand health trends. As we move forward, drones and autonomous technology doing detection will be an important part of ensuring public safety,” said Andy Card, Director of Draganfly and former Secretary of Transportation and White House Chief of Staff.
Dr. Jack Chow, advisor to the Vital Intelligence Project and the former first Assistant Director-General of the World Health Organization (WHO) on infectious diseases said: “With fighting epidemics rising as a global priority, new versatile technologies, such as humanitarian mission UAVs, are immediately needed to detect and track outbreaks so that critical interventions can be deployed sooner and with greater effectiveness.”
About University of South Australia
The University of South Australia (UniSA) is a public research university in the Australian state of South Australia. It is a founding member of the Australian Technology Network of universities and is the largest university in South Australia with approximately 32,000 students. UniSA is among the world's top universities, ranked in the World's Top 50 Under 50 by both the Quacarelli Symonds (QS) World University Ranking (#25) and Times Higher Education (THE) (#26). Under the University's Act, its original mission was "to preserve, extend and disseminate knowledge through teaching, research, scholarship and consultancy, and to provide educational programs that will enhance the diverse cultural life of the wider community".
About Draganfly
Draganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge, UVS and software that revolutionizes the way people do business. Recognized as being at the forefront of technology for over 21 years, Draganfly is an award-winning, industry-leading manufacturer within the commercial UAV and UVS space, serving the public safety, agriculture, industrial inspections and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money and lives.
For more information on Draganfly, please visit us at
draganfly.com.
For additional investor information, visit
https://www.thecse.com/en/listings/technology/draganfly-inc,
https://www.otcmarkets.com/stock/DFLYF/overview or
https://www.boerse-frankfurt.de/aktie/draganfly-inc.
Media Contact
Arian Hopkins
email: arian@businessinstincts.com
Company Contact
Phone: 1-306-955-9907
Email: info@draganfly.com
Forward-Looking Statements
This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the current outbreak of the novel coronavirus known as COVID-19 on the Company’s business, operations and financial condition, the successful integration of technology, the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.
Attachment
Vital Intelligence Project
